Ginkgo Bioworks Holdings, Inc.

DNANYSEUSD
8.02 USD
1.04 (11.50%)🟢LIVE (AS OF 02:57 PM EDT)
🟢Market: OPEN
Open?$8.90
High?$9.15
Low?$8.00
Prev. Close?$9.05
Volume?1.1M
Avg. Volume?1.4M
VWAP?$8.31
Rel. Volume?0.81x
Bid / Ask
Bid?$9.03 × 100
Ask?$8.04 × 100
Spread?-$0.99
Midpoint?$8.54
Valuation & Ratios
Market Cap?591.2M
Shares Out?53.4M
Float?40.3M
Float %?80.6%
P/E Ratio?N/A
P/B Ratio?1.33
EPS?-$4.66
Dividend?0.00%
Ex-Dividend?N/A

DNA is currently priced at $8.02. DNA shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. DNA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 4, 2026.

RelatedTWST
News
Profile
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Employees
485
Market Cap
570.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-04-19
Address
27 DRYDOCK AVENUE
BOSTON, MA 02210
Phone: (877) 442-5362
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
27
Short Sent.?
71
Piotroski F-Score?1/9Weak
Altman Z-Score?-8.30Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.24%High
Short Interest?4.5M
Days to Cover?2.7
Free Float40.3M
Avg Daily Volume1.7M
Settlement Date2026-05-15
Financial Health
Current Ratio?5.15Strong
Quick Ratio?5.15Strong
Cash Ratio?1.81Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
91
1.33CHEAP
P/S?
Peers
100
S&P
36
4.18FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.9CHEAP
EV/Sales?
Peers
100
S&P
58
3.17FAIR
Returns & Efficiency
ROE?
S&P
3
-68.7%WEAK
ROA?
S&P
3
-29.5%WEAK
Cash Flow & Enterprise
FCF?$-168200000
Enterprise Value?$447.3M
Fundamentals ratios updated end of day